Attaching importance to mechanical perfusion of donor liver and promoting high-quality development of liver transplantation
-
摘要: 随着器官捐献数量不断增加和扩大标准供者(ECD)供肝定义不断拓展,供肝质量必然成为影响肝移植高质量发展的突出问题,也是相关领域的研究重点。最大限度解决器官短缺和推动器官移植高质量发展是我国器官捐献与移植事业发展的方向。近年来,利用机械灌注(MP)对供肝进行灌注、保存、评估及修复,已成为当前国际上提高肝移植质量的研究热点。本文针对国内外ECD供肝的不同应用情况,结合国际上MP研究进展和本中心有关研究经验,探讨整合器官保护技术建设器官重症监护室(ICU)的可行性,拟在推动我国器官移植高质量发展同时,进一步丰富器官捐献与移植“中国模式”的技术内涵。
-
关键词:
- 机械灌注 /
- 器官移植 /
- 肝移植 /
- 重症监护室(ICU) /
- 扩大标准供者(ECD) /
- 器官捐献 /
- 器官保护 /
- 体外膜肺氧合
Abstract: With the increasing quantity of organ donors and the continual expansion of the definition of extended criteria donor (ECD) livers, the quality of donor liver has become a prominent issue affecting the high-quality development of liver transplantation, which is also the study focus in related fields. Resolving the shortage of organs to the maximal extent and promoting the high-quality development of organ transplantation lead the development direction of organ donation and transplantation in China. In recent years, the application of mechanical perfusion (MP) for the perfusion, preservation, evaluation and repair of donor liver has become a hot topic to improve the quality of liver transplantation within the international community. In this article, according to different conditions of the application of ECD livers in liver transplantation at home and abroad in combination with the research progress on MP in the international community and relevant research experience of our center, the feasibility of establishing an organ intensive care unit (ICU) with integrated organ protection techniques was discussed, aiming to promote the high-quality development of organ transplantation in China and further expand the technical connotation of the "Chinese model" of organ donation and transplantation. -
[1] CZIGANY Z, TACKE F, LURJE G. Evolving trends in machine liver perfusion: comments on clinical end points and selection criteria[J]. Gastroenterology, 2019, 157(4):1166-1167. DOI: 10.1053/j.gastro.2019.02.051. [2] WHITE SL. Nudging the organ discard problem[J]. Transplantation, 2017, 101(7):1518-1519. DOI: 10.1097/TP.0000000000001718. [3] NAIR A, HASHIMOTO K. Extended criteria donors in liver transplantation-from marginality to mainstream[J]. Hepatobiliary Surg Nutr, 2018, 7(5):386-388. DOI: 10.21037/hbsn.2018.06.08. [4] GANDOLFINI I, BUZIO C, ZANELLI P, et al. The kidney donor profile index (KDPI) of marginal donors allocated by standardized pretransplant donor biopsy assessment: distribution and association with graft outcomes[J]. Am J Transplant, 2014, 14(11):2515-2525. DOI: 10.1111/ajt.12928. [5] FUDIM M, DAVIS ME, JENKINS C, et al. Marginal donor use in patients undergoing heart transplantation with left ventricular assist device explantation[J]. Ann Thorac Surg, 2015, 100(6):2117-2126. DOI: 10.1016/j.athoracsur.2015.05.110. [6] ADAM R, KARAM V, CAILLIEZ V, et al. 2018 Annual Report of the European Liver Transplant Registry (ELTR)-50-year evolution of liver transplantation[J]. Transpl Int, 2018, 31(12):1293-1317. DOI: 10.1111/tri.13358. [7] 黄洁夫.中国器官移植发展报告(2015-2018)[R].昆明: 中国器官移植发展基金会, 2019. [8] CZIGANY Z, LURJE I, TOLBA RH, et al. Machine perfusion for liver transplantation in the era of marginal organs-new kids on the block[J]. Liver Int, 2019, 39(2):228-249. DOI: 10.1111/liv.13946. [9] HERRERO TORRES MA, DOMNIGUEZ BASTANTE M, MOLINA RAYA A, et al. Eight years of extracorporeal membrane oxygenation in liver transplantation: our experience[J]. Transplant Proc, 2020, 52(2):572-574. DOI: 10.1016/j.transproceed.2019.11.050. [10] HAGNESS M, FOSS S, SøRENSEN DW, et al. Liver transplant after normothermic regional perfusion from controlled donors after circulatory death: the Norwegian experience[J]. Transplant Proc, 2019, 51(2):475-478. DOI: 10.1016/j.transproceed.2019.01.066. [11] HESSHEIMER AJ, COLL E, TORRES F, et al. Normothermic regional perfusion vs. super-rapid recovery in controlled donation after circulatory death liver transplantation[J]. J Hepatol, 2019, 70(4):658-665. DOI: 10.1016/j.jhep.2018.12.013. [12] CHO Y, KIM C, KANG B. Risk of bias assessment of randomised controlled trials referenced in the 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care: a cross-sectional review[J]. BMJ Open, 2019, 9(5):e023725. DOI: 10.1136/bmjopen-2018-023725. [13] ZHANG Y, ZHANG Y, ZHANG M, et al. Hypothermic machine perfusion reduces the incidences of early allograft dysfunction and biliary complications and improves 1-year graft survival after human liver transplantation: a Meta-analysis[J]. Medicine (Baltimore), 2019, 98(23):e16033. DOI: 10.1097/MD.0000000000016033. [14] KRON P, SCHLEGEL A, MANCINA L, et al. Hypothermic oxygenated perfusion (HOPE) for fatty liver grafts in rats and humans[J]. J Hepatol, 2017, 68(1):82-91. DOI: 10.1016/j.jhep.2017.08.028. [15] THORNE AM, UBBINK R, BRÜGGENWIRTH IMA, et al. Hyperthermia-induced changes in liver physiology and metabolism: a rationale for hyperthermic machine perfusion[J]. Am J Physiol Gastrointest Liver Physiol, 2020, 319(1):G43-G50. DOI: 10.1152/ajpgi.00101.2020. [16] SCHLEGEL A, MULLER X, KALISVAART M, et al. Outcomes of DCD liver transplantation using organs treated by hypothermic oxygenated perfusion before implantation[J]. J Hepatol, 2019, 70(1):50-57. DOI: 10.1016/j.jhep.2018.10.005. [17] MARTINS PN, BUCHWALD JE, MERGENTAL H, et al. The role of normothermic machine perfusion in liver transplantation[J]. Int J Surg, 2020, 82(Suppl):52-60. DOI: 10.1016/j.ijsu.2020.05.026. [18] NASRALLA D, COUSSIOS CC, MERGENTAL H, et al. A randomized trial of normothermic preservation in liver transplantation[J]. Nature, 2018, 557(7703):50-56. DOI: 10.1038/s41586-018-0047-9. [19] ESHMUMINOV D, BECKER D, BAUTISTA BORREGO L, et al. An integrated perfusion machine preserves injured human livers for 1 week[J]. Nat Biotechnol, 2020, 38(2):189-198. DOI: 10.1038/s41587-019-0374-x. [20] VON HORN C, BABA HA, HANNAERT P, et al. Controlled oxygenated rewarming up to normothermia for pretransplant reconditioning of liver grafts[J]. Clin Transplant, 2017, 31(11). DOI: 10.1111/ctr.13101. [21] DE VRIES Y, MATTON APM, NIJSTEN MWN, et al. Pretransplant sequential hypo- and normothermic machine perfusion of suboptimal livers donated after circulatory death using a hemoglobin-based oxygen carrier perfusion solution[J]. Am J Transplant, 2019, 19(4):1202-1211. DOI: 10.1111/ajt.15228. [22] DENGU F, ABBAS SH, EBELING G, et al. Normothermic machine perfusion (NMP) of the liver as a platform for therapeutic interventions during ex-vivo liver preservation: a review[J]. J Clin Med, 2020, 9(4):1046. DOI: 10.3390/jcm9041046. [23] FENG S, GOODRICH NP, BRAGG-GRESHAM JL, et al. Characteristics associated with liver graft failure: the concept of a donor risk index[J]. Am J Transplant, 2006, 6(4):783-790. DOI: 10.1111/j.1600-6143.2006.01242.x. [24] WINTER A, FÉRAY C, AUDUREAU E, et al. A donor quality index for liver transplantation: development, internal and external validation[J]. Sci Rep, 2018, 8(1): 9871. DOI: 10.1038/s41598-018-27960-7. [25] SCHLEGEL A, KALISVAART M, SCALERA I, et al. The UK DCD risk score: a new proposal to define futility in donation-after-circulatory-death liver transplantation[J]. J Hepatol, 2018, 68(3):456-464. DOI: 10.1016/j.jhep.2017.10.034. [26] DE MEIJER VE, FUJIYOSHI M, PORTE RJ. Ex situ machine perfusion strategies in liver transplantation[J]. J Hepatol, 2019, 70(1):203-205. DOI: 10.1016/j.jhep. 2018.09.019. [27] BHOGAL RH, MIRZA DF, AFFORD SC, et al. Biomarkers of liver injury during transplantation in an era of machine perfusion[J]. Int J Mol Sci, 2020, 21(5):1578. DOI: 10.3390/ijms21051578. [28] MATTON APM, DE VRIES Y, BURLAGE LC, et al. Biliary bicarbonate, pH, and glucose are suitable biomarkers of biliary viability during ex situ normothermic machine perfusion of human donor livers[J]. Transplantation, 2019, 103(7):1405-1413. DOI: 10.1097/TP.0000000000002500. [29] WATSON CJE, KOSMOLIAPTSIS V, PLEY C, et al. Observations on the ex situ perfusion of livers for transplantation[J]. Am J Transplant, 2018, 18(8):2005-2020. DOI: 10.1111/ajt.14687. [30] SCHREITER T, SOWA JP, SCHLATTJAN M, et al. Human ex-vivo liver model for acetaminophen-induced liver damage[J]. Sci Rep, 2016, 6:31916. DOI: 10.1038/srep31916.
点击查看大图
计量
- 文章访问数: 453
- HTML全文浏览量: 324
- PDF下载量: 73
- 被引次数: 0